TherapeuticsMD (TXMD) P/E (2011 - 2026)
TherapeuticsMD (TXMD) P/E from Mar 31, 2011 to Jun 3, 2026. The TTM TherapeuticsMD (TXMD) P/E is 126.67. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of TherapeuticsMD (TXMD)
| Year | P/E | Change |
|---|---|---|
| 2026 | 126.67 | -482.72% |
| 2025 | -33.10 | +627.53% |
| 2024 | -4.55 | -1567.13% |
| 2023 | 0.31 | -105.76% |
| 2022 | -5.39 | +536.03% |
| 2021 | -0.85 | -53.79% |
| 2020 | -1.83 | -46.40% |
| 2019 | -3.42 | -47.91% |
| 2018 | -6.57 | -57.94% |
| 2017 | -15.61 | +19.70% |
| 2016 | -13.04 | -38.86% |
| 2015 | -21.33 | +70.98% |
| 2014 | -12.48 | -50.73% |
| 2013 | -25.32 | +193.74% |
| 2012 | -8.62 | -61.52% |
| 2011 | -22.40 | N/A |
Comparison TherapeuticsMD (TXMD) P/E with competitors
TherapeuticsMD (TXMD) P/E is 126.67.